ロード中...
Treatment with XAV-939 prevents in vitro calcification of human valvular interstitial cells
The development of a substance or inhibitor-based treatment strategy for the prevention of aortic valve stenosis is a challenge and a main focus of medical research in this area. One strategy may be to use the tankyrase inhibitor XAV-939, which leads to Axin stabilisation and subsequent destruction...
保存先:
| 出版年: | PLoS One |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Public Library of Science
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6286025/ https://ncbi.nlm.nih.gov/pubmed/30532256 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0208774 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|